Biomedical Engineering Reference
In-Depth Information
synthase and 6-phospho-3-hexuloisomerase. Appl. Microbiol.
Biotechnol. 76(2), 439-445.
37. Tamada Y, Swanson BA, Arabshahi A, Frey PA. (1994)
Preparation and characterization of a bifunctional fusion
enzyme composed of UDP-galactose 4-epimerase and galac-
tose-1-P uridylyltransferase. Bioconjug. Chem. 5(6), 660-665.
38. Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP,
Berry CC, et al. (2010) Efficacy of gene therapy for X-linked
severe combined immunodeficiency. N. Engl. J. Med. 363(4),
355-364.
39. Zhou Q-H, Sumbria R, Hui EK-W, Lu JZ, Boado RJ, Pardridge
WM. (2011) Neuroprotection with a brain-penetrating biologic
tumor necrosis factor inhibitor. J. Pharmacol. Exp. Ther.
339(2), 618-623.
40. Jain A, Chasoo G, Singh SK, Saxena AK, Jain SK. (2011)
Transferrin-appended
temozolomide delivery to brain: in vitro characterisation. J
Microencapsul. 28(1), 21-28.
41. Chu L, Robinson DK. (2001) Industrial choices for protein
production by large-scale cell culture. Curr. Opin. Biotechnol.
12(2), 180-187.
42. Glaesner W, Millican J, Vick AM. (2009) GLP-1 analog fusion
proteins. US 2009/0074769 A1. US.
43. Forthal DN, Gach JS, Landucci G, Jez J, Strasser R, Kunert R,
et al. (2010) Fc-glycosylation influences Fc
g
receptor binding
and cell-mediated anti-HIV activity of monoclonal antibody
2G12. J. Immunol. 185(11), 6876-6882.
44. Ghirlando R, Lund J, Goodall M, Jefferis R. (1999) Glycosylation
of human IgG-Fc: influences on structure revealed by differential
scanning micro-calorimetry. Immunol. Lett. 68(1), 47-52.
45. Beasley D. (2011) FDA to issue biosimilar guidance in 2011.
Reuters 9. May.
PEGylated
nanoparticles
for
Search WWH ::
Custom Search